BSE - Free Realtime Quote INR

Narayana Hrudayalaya Limited (NH.BO)

1,748.95
+10.15
+(0.58%)
As of 9:44:42 AM GMT+5:30. Market Open.
Loading Chart for NH.BO
  • Previous Close 1,738.80
  • Open 1,735.05
  • Bid 1,746.55 x --
  • Ask 1,748.90 x --
  • Day's Range 1,735.05 - 1,755.90
  • 52 Week Range 1,171.35 - 1,872.85
  • Volume 514
  • Avg. Volume 40,615
  • Market Cap (intraday) 358.071B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 45.31
  • EPS (TTM) 38.60
  • Earnings Date Jul 31, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 4.50 (0.26%)
  • Ex-Dividend Date Jul 31, 2025
  • 1y Target Est 1,699.15

Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

www.narayanahealth.org

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NH.BO

View More

Performance Overview: NH.BO

Trailing total returns as of 6/5/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

NH.BO
37.32%
S&P BSE SENSEX (^BSESN)
4.23%

1-Year Return

NH.BO
47.97%
S&P BSE SENSEX (^BSESN)
9.50%

3-Year Return

NH.BO
171.48%
S&P BSE SENSEX (^BSESN)
46.04%

5-Year Return

NH.BO
514.55%
S&P BSE SENSEX (^BSESN)
137.54%

Compare To: NH.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NH.BO

View More

Valuation Measures

Annual
As of 6/3/2025
  • Market Cap

    355.99B

  • Enterprise Value

    362.75B

  • Trailing P/E

    45.10

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.49

  • Price/Book (mrq)

    9.81

  • Enterprise Value/Revenue

    6.62

  • Enterprise Value/EBITDA

    26.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.41%

  • Return on Assets (ttm)

    9.68%

  • Return on Equity (ttm)

    24.25%

  • Revenue (ttm)

    54.83B

  • Net Income Avi to Common (ttm)

    7.89B

  • Diluted EPS (ttm)

    38.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.27B

  • Total Debt/Equity (mrq)

    66.93%

  • Levered Free Cash Flow (ttm)

    -2.73B

Research Analysis: NH.BO

View More

Company Insights: NH.BO

Research Reports: NH.BO

View More

People Also Watch